AIMCA
NKTR icon

Alberta Investment Management Corp (AIMCo)’s Nektar Therapeutics NKTR Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-9,503
Closed -$1.75M – 872
2016
Q4 		$1.75M Buy
9,503
+3,469
+57% +$705K 0.02% 481
2016
Q3 		$1.55M Buy
6,034
+3,455
+134% +$890K 0.02% 477
2016
Q2 		$551K Buy
+2,579
New +$576K 0.01% 556

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s NKTR Position: Q1 2017 in Review

Alberta Investment Management Corp (AIMCo) sold out of Nektar Therapeutics (NKTR) in Q1 2017, closing a stake of 9,503 shares — an estimated $1.75M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in NKTR in Q2 2016 and held it in 3 quarters. The position peaked at $1.75M in Q4 2016. 201 funds tracked by Wall St. Rank hold NKTR as of Q1 2017.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Nektar Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 9,503 Nektar Therapeutics shares in Q1 2017, an estimated $1.75M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Nektar Therapeutics in Q2 2016 and held it in 3 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Nektar Therapeutics position peaked at $1.75M in Q4 2016.
  • 201 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2017.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2017, filed 15 May 2017.